Stool testing (microbiome analysis) is increasingly marketed as a tool for longevity. It can reveal gut microbiota composition, which is linked to inflammation, metabolism, and immune function—factors that may influence lifespan. However, the evidence for a direct causal role of specific microbiome profiles in human longevity remains weak. Most findings come from animal models or cross-sectional studies (e.g., centenarians), which do not prove causation. Moreover, stool samples are highly variable due to diet, medications, and lifestyle, making a single snapshot of limited predictive value. From a scientific standpoint, stool testing is an exploratory tool, not a validated longevity marker. Users should interpret results cautiously and avoid making drastic supplement or diet changes based solely on such tests. Safety note: stool tests are non-invasive, but commercial interpretations often overstate clinical relevance. For evidence-based longevity, established biomarkers (HbA1c, CRP, lipids) and lifestyle factors (exercise, sleep, nutrition) remain more reliable.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-454036afe48fa5671df4d8c7